Next Generation News and Research

RSS

Dementia patients often receive different treatment after hospital transfer, study finds

It is common for individuals seeking medical care for symptoms of concern to go to the nearest hospital. Physicians there may determine the facility cannot provide the care they believe the patient needs and recommend transfer to another hospital offering a higher level of care or specialized services.

28 Nov 2023

Researchers make great strides in combating pneumococcal pneumonia

The global impact of the coronavirus pandemic has ignited a renewed focus on emerging and re-emerging infectious diseases.

28 Nov 2023

Synthetic biologists develop versatile platform for targeted drug delivery

In recent years, cell and gene therapies have shown significant promise for treating cancer, cystic fibrosis, diabetes, heart disease, HIV/AIDS and other difficult-to-treat diseases.

27 Nov 2023

Ultra-high resolution MRI scanner offers new opportunities for brain research

An intense international effort to improve the resolution of magnetic resonance imaging (MRI) for studying the human brain has culminated in an ultra-high resolution 7 Tesla scanner that records up to 10 times more detail than current 7T scanners and over 50 times more detail than current 3T scanners, the mainstay of most hospitals.

27 Nov 2023

Hormone therapy for transmasculine individuals may be safer than previously thought

A common concern about gender-affirming hormone therapy for transmasculine people is the risk of red blood cell volume changes and erythrocytosis, a high concentration of red blood cells, with the use of prescribed testosterone.

27 Nov 2023

Ingenza and Phibro Ethanol accelerate the green fuel transition

Ingenza and Phibro Ethanol – a division of Phibro Animal Health Corporation – have joined forces to engineer a novel yeast strain that will increase yield in the commercial production of bioethanol under both challenging and conventional environmental conditions, further driving the switch to clean biofuels.

From Ingenza Ltd 24 Nov 2023

Integra Launches Sterile Polypropylene Reagent Reservoirs With Sureflo™ Technology

INTEGRA Biosciences has extended its reagent reservoir portfolio to include 10 and 25 ml sterile polypropylene reservoirs with SureFlo™ anti-sealing technology.

From INTEGRA Biosciences 23 Nov 2023

New insights into genetic risk factors for early breast cancer in women of Kazakh ethnicity

A new research paper was published in Oncotarget's Volume 14 on October 4, 2023, entitled, "Determination of genetic predisposition to early breast cancer in women of Kazakh ethnicity."

22 Nov 2023

MaxCyte joins the alliance for mRNA medicines (AMM) as a founding member

MaxCyte, Inc. today announced that it has joined the Alliance for mRNA Medicines, as a founding member.

From MaxCyte, Inc. 22 Nov 2023

St. Jude scientists discover potential CAR T cell therapy target for brain and solid tumors

Findings from St. Jude Children's Research Hospital are moving the field of cancer immunotherapy one step closer to treating brain and solid tumors.

21 Nov 2023

New organoid model could lead to personalized treatments for colon-related diseases

A team at the Medical University of South Carolina and Cincinnati Children's has developed a sophisticated model for studying the diseased colon that could lead to the development of personalized treatments for colon-related diseases, such as cancer and inflammatory bowel disease (IBD).

20 Nov 2023

RIT scientist earns NIH award to support research on building the next generation of drugs

Rochester Institute of Technology's Emiliano Brini, assistant professor in the School of Chemistry and Materials Science, has received an award from the National Institutes of Health (NIH) to support his research on building the next generation of drugs.

17 Nov 2023

Focusing on innovation for planetary health

The University of Bonn has once again recruited an exceptional talent: Ina Danquah has been appointed as the new Hertz-Chair "Innovation for Planetary Health" at the "University of Excellence Bonn".

17 Nov 2023

B-BiTE modality enhances anti-myeloma effects of clinically available antibodies

Multiple myeloma still appears to be an incurable hematological malignancy. One of the reasons is that myeloma cells can be heterogenous and acquire resistance after anti-myeloma treatment.

16 Nov 2023

American Heart Association commits to equity in cardiovascular health outcomes

Disparities in health care persist, with Hispanic and Black adults reporting less satisfaction with their interactions with physicians, leading to poorer quality of care and health outcomes.

16 Nov 2023

AI model predicts patient outcomes across multiple cancer types

Investigators from the UCLA Health Jonsson Comprehensive Cancer Center have developed an artificial intelligence (AI) model based on epigenetic factors that is able to predict patient outcomes successfully across multiple cancer types.

16 Nov 2023

MaxCyte joins the Alliance for mRNA Medicines (AMM) as a founding member

MaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and innovative bioprocessing applications, today announced that it has joined the Alliance for mRNA Medicines (AMM), as a founding member.

From MaxCyte, Inc. 16 Nov 2023

Fecal microbiota transplantation boosts survival in metastatic colorectal cancer treatment

A recent study in eClinicalMedicine found that fecal microbiota transplantation, combined with fruquintinib and tislelizumab, significantly improved survival rates in patients with microsatellite stable metastatic colorectal cancer, showing manageable safety and notable increases in progression-free and overall survival.

15 Nov 2023

Scientists develop an improved method to study Parkinson's disease in the lab

A recent study published in Progress in Neurobiology and led by researchers at the University of Arizona College of Medicine – Tucson has developed an improved method to study Parkinson's disease in the lab.

15 Nov 2023

Engineering approach reveals surprising macrophage phenotype with best tumor-targeting ability

Macrophages, a type of white blood cell that can destroy invading pathogens, have an innate ability to infiltrate tumor cells, making them a potentially important tool in treatments that use transplanted cells to fight disease, known as cell therapy.

15 Nov 2023

Next Generation News and Research

Dementia patients often receive different treatment after hospital transfer, study finds

Researchers make great strides in combating pneumococcal pneumonia

Synthetic biologists develop versatile platform for targeted drug delivery

Ultra-high resolution MRI scanner offers new opportunities for brain research

Hormone therapy for transmasculine individuals may be safer than previously thought

Ingenza and Phibro Ethanol accelerate the green fuel transition

Integra Launches Sterile Polypropylene Reagent Reservoirs With Sureflo™ Technology

New insights into genetic risk factors for early breast cancer in women of Kazakh ethnicity

MaxCyte joins the alliance for mRNA medicines (AMM) as a founding member

St. Jude scientists discover potential CAR T cell therapy target for brain and solid tumors

New organoid model could lead to personalized treatments for colon-related diseases

RIT scientist earns NIH award to support research on building the next generation of drugs

Focusing on innovation for planetary health

B-BiTE modality enhances anti-myeloma effects of clinically available antibodies

American Heart Association commits to equity in cardiovascular health outcomes

AI model predicts patient outcomes across multiple cancer types

MaxCyte joins the Alliance for mRNA Medicines (AMM) as a founding member

Fecal microbiota transplantation boosts survival in metastatic colorectal cancer treatment

Scientists develop an improved method to study Parkinson's disease in the lab

Engineering approach reveals surprising macrophage phenotype with best tumor-targeting ability

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News